Facility

Today Innovacell operates one of Europe’s largest good manufacturing practice (GMP) certified production facilities, which is fully equipped and established for the proliferation of autologous muscle cells. The current production capacity amounts to approx. 2,500 units per annum. Depending on the demand for therapies, this capacity can be doubled within six months, as required.

In addition, the company operates a dedicated laboratory for cryopreservation. Innovacell’s cryopreservation method is key to storing, handling and shipping therapeutic cell cultures to the highest available safety standards. Innovacell’s laboratory and productions facilities are located in the Life Science Center of Innsbruck, Austria.